Search - tctmd.com

Displaying 281 - 300 of 455

Sort: Relevancy | Date

News Conference News AHA 2017

One in Eight US Patients With MI or Stroke Under Age 65 Are Uninsured, Face Catastrophic Costs

Shelley Wood

November 14, 2017

News Conference News AHA 2017

Low High-Sensitivity Troponin I Cutoff May Allow Discharge From ED for Many

Todd Neale

November 11, 2017

News Conference News TCT 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Yael L. Maxwell

October 31, 2017

News Daily News

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

Michael O'Riordan

October 19, 2017

News Features

Conference Organizers, Physicians Wary as Direct Industry Sponsorship Winds Down in Europe

Todd Neale

October 16, 2017

News Daily News

Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues

Caitlin E. Cox

October 06, 2017

News Daily News

Modified Risk Score for ED Chest Pain Patients Reduces Hospital Stays, Lowers Costs

Michael O'Riordan

October 03, 2017

News Daily News

‘A Healthy Brexit’? How a Split From EU Could Affect UK Health System

Yael L. Maxwell

October 02, 2017

News Daily News

Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease

Yael L. Maxwell

September 15, 2017

News Opinion Fellow Talk

Cost Awareness and Fellowship Education

Amit K. Gupta, MBBS, MD

August 31, 2017

News Conference News ESC 2017

Underweight and Overlooked: Low BMI Patients May Be Highest-Risk Post-PCI

Shelley Wood

August 26, 2017

News Daily News

CDC Says Only One in Three Post-MI Patients Get Outpatient Cardiac Rehab

L.A. McKeown

August 25, 2017

News Daily News

Evolocumab Not Cost-Effective at Current List Price

Michael O'Riordan

August 23, 2017

News Daily News

TAVR in the US: Regional Variations in Numbers, Outcomes

Michael O'Riordan

August 22, 2017

News Daily News

Obese Cardiac Surgery Patients a Burden on ICU Resources

Michael O'Riordan

August 11, 2017

News Daily News

Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study

Leah Lawrence

July 24, 2017

News Daily News

ECGs Ordered After One in Five Annual Health Exams

Shelley Wood

July 13, 2017

News Industry News

Innovative Cardiovascular Solutions Raises $5.0 Million in Series B Financing for Advanced Device Development and Initiation of U.S. Clinical Activities

July 11, 2017

News Conference News SCCT 2017

Faster, On-site FFRCT May Be on the Horizon Through Innovation and Collaboration

Yael L. Maxwell

July 09, 2017

News Daily News

Biomedical Research in CVD: More Investment Today Will Yield Long-term Rewards

Caitlin E. Cox

June 29, 2017

Advertisement

One in Eight US Patients With MI or Stroke Under Age 65 Are Uninsured, Face Catastrophic Costs

Low High-Sensitivity Troponin I Cutoff May Allow Discharge From ED for Many

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

Conference Organizers, Physicians Wary as Direct Industry Sponsorship Winds Down in Europe

Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues

Modified Risk Score for ED Chest Pain Patients Reduces Hospital Stays, Lowers Costs

‘A Healthy Brexit’? How a Split From EU Could Affect UK Health System

Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease

Cost Awareness and Fellowship Education

Underweight and Overlooked: Low BMI Patients May Be Highest-Risk Post-PCI

CDC Says Only One in Three Post-MI Patients Get Outpatient Cardiac Rehab

Evolocumab Not Cost-Effective at Current List Price

TAVR in the US: Regional Variations in Numbers, Outcomes

Obese Cardiac Surgery Patients a Burden on ICU Resources

Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study

ECGs Ordered After One in Five Annual Health Exams

Innovative Cardiovascular Solutions Raises $5.0 Million in Series B Financing for Advanced Device Development and Initiation of U.S. Clinical Activities

Faster, On-site FFRCT May Be on the Horizon Through Innovation and Collaboration

Biomedical Research in CVD: More Investment Today Will Yield Long-term Rewards

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content